Skip to main content
. 2014 Nov;35(11):2070–2075. doi: 10.3174/ajnr.A4029

Fig 2.

Fig 2.

Functional improvement of patients who were alive at the time of discharge (n = 87) according to leukoaraiosis severity (unadjusted). Compared with patients with absent-to-moderate leukoaraiosis, patients with severe leukoaraiosis are significantly less likely to have any improvement on the mRS from discharge to 90 days (50% versus 79% of surviving patients [21% versus 59% of all patients, respectively]; P = .034; darker shades indicate less improvement).